ArticleFrontiers in neuroinformatics2022
EpiBOX: An Automated Platform for Long-Term Biosignal Collection.
Article in Frontiers in neuroinformatics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 5 citations in OpenAlex.
- A scalable platform for acquisition of high-fidelity human intracranial EEG with minimal clinical burden.PloS one · 2024Article
- PreEpiSeizures: description and outcomes of physiological data acquisition using wearable devices during video-EEG monitoring in people with epilepsy.Frontiers in physiology · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Biosignals represent a first-line source of information to understand the behavior and state of human biological systems, often used in machine learning problems. However, the development of healthcare-related algorithms that are both personalized and robust requires the collection of large volumes of data to capture representative instances of all possible states. While the rise of flexible biosignal acquisition solutions has enabled the expedition of data collection, they often require complicated frameworks or do not provide the customization required in some research contexts. As such, EpiBOX was developed as an open-source, standalone, and automated platform that enables the long-term acquisition of biosignals, passable to be operated by individuals with low technological proficiency. In particular, in this paper, we present an in-depth explanation of the framework, methods for the evaluation of its performance, and the corresponding findings regarding the perspective of the end-user. The impact of the network connection on data transfer latency was studied, demonstrating innocuous latency values for reasonable signal strengths and manageable latency values even when the connection was unstable. Moreover, performance profiling of the EpiBOX user interface (mobile application) indicates a suitable performance in all aspects, providing an encouraging outlook on adherence to the system. Finally, the experience of our research group is described as a use case, indicating a promising outlook regarding the use of the EpiBOX framework within similar contexts. As a byproduct of these features, our hope is that by empowering physicians, technicians, and monitored subjects to supervise the biosignal collection process, we enable researchers to scale biosignal collection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.